基于抗生素治疗和血流动力学优化的院前集束化治疗与脓毒性休克患者30天死亡率下降相关
该回顾性研究纳入2016年5月至2021年3月需院前移动ICU干预的529例脓毒性休克患者,最终分析354例(67%)。主要疑似感染来源为肺部(49%)、消化道(25%)和泌尿系(13%)。仅71例(20%)接受了院前抗生素治疗和液体扩容。经IPTW加权的log二项回归显示,完成院前集束化治疗与30天死亡率显著相关(未调整RR 0.56,95%CI 0.33-0.89,p=0.02;调整后RR 0.52,95%CI 0.27-0.93,p=0.03)。总体30天死亡率为32%。
要点
- 在需院前移动ICU干预的脓毒性休克患者中,完成院前抗生素+液体扩容集束化治疗与30天死亡率降低相关(调整后RR 0.52,95%CI 0.27-0.93,p=0.03)。
- 该研究共纳入529例,最终分析354例(67%),仅71例(20%)接受了院前抗生素治疗和液体扩容。
- 总体30天死亡率为32%;疑似感染来源以肺部(49%)、消化道(25%)、泌尿系(13%)为主。
- 未调整分析同样显示集束化治疗完成与30天死亡率相关(RR 0.56,95%CI 0.33-0.89,p=0.02)。
适用人群与场景
- 2016年5月至2021年3月期间,需院前移动ICU(mICU)干预的脓毒性休克(SS)患者,回顾性分析。
- 共纳入529例,最终分析354例(67%)。
处置流程与药物剂量
- 院前集束化治疗包括抗生素治疗和血流动力学优化,血流动力学优化定义为液体扩容至少10 mL·kg⁻¹·hr⁻¹。
研究设计与关键结果
- 研究类型:回顾性分析;样本量:纳入529例,分析354例(67%);人群:需院前mICU干预的脓毒性休克患者;干预:无(观察性研究);主要终点:30天死亡率。
- 疑似感染来源:肺部49%、消化道25%、泌尿系13%。
- 总体30天死亡率为32%;71例(20%)接受了院前抗生素治疗和液体扩容。
- 经IPTW加权的log二项回归显示,完成院前集束化治疗与30天死亡率显著相关:未调整RR 0.56(95%CI 0.33-0.89),p=0.02;调整后RR 0.52(95%CI 0.27-0.93),p=0.03。
证据类型、等级与局限
- 证据类型:回顾性分析;采用IPTW倾向性评分方法。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于抗生素治疗和血流动力学优化的院前集束化治疗与脓毒性休克患者30天死亡率下降相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aims to investigate the association between the 30-day mortality in patients with septic shock (SS) and a prehospital bundle of care completion, antibiotic therapy administration, and hemodynamic optimization defined as a fluid expansion of at least 10 mL.kg -1 .hr -1 .
DESIGN: To assess the association between prehospital BUndle of Care (BUC) completion and 30-day mortality, the inverse probability treatment weighting (IPTW) propensity method was performed.
SETTING: International guidelines recommend early treatment implementation in order to reduce SS mortality. More than one single treatment, a bundle of care, including antibiotic therapy and hemodynamic optimization, is more efficient.
PATIENTS: From May 2016 to March 2021, patients with SS requiring prehospital mobile ICU (mICU) intervention were retrospectively analyzed.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among the 529 patients with SS requiring action by the mICU enrolled in this study, 354 (67%) were analyzed. Presumed pulmonary, digestive, and urinary infections were the cause of the SS in 49%, 25%, and 13% of the cases, respectively. The overall 30-day mortality was 32%. Seventy-one patients (20%) received prehospital antibiotic therapy and fluid expansion. Log binomial regression weighted with IPTW resulted in a significant association between 30-day mortality and prehospital BUC completion (respiratory rate [RR] of 0.56 [0.33-0.89]; p = 0.02 and adjusted RR 0.52 [0.27-0.93]; p = 0.03).
CONCLUSIONS: A prehospital bundle of care, based on antibiotic therapy and hemodynamic optimization, is associated with a 30-day mortality decrease among patients suffering from SS cared for by an mICU.
参考来源
- Jouffroy R, Gilbert B, Tourtier JP, et al. Prehospital Bundle of Care Based on Antibiotic Therapy and Hemodynamic Optimization Is Associated With a 30-Day Mortality Decrease in Patients With Septic Shock. Crit Care Med. 2022. PMID: 35904262. doi:10.1097/CCM.0000000000005625
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。